{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:55:03Z","timestamp":1791975303046,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.prp.2021.153592","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T23:08:14Z","timestamp":1629846494000},"page":"153592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP)"],"prefix":"10.1016","volume":"226","author":[{"given":"Antonio","family":"Travaglino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-2333","authenticated-orcid":false,"given":"Antonio","family":"Raffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annarita","family":"Gencarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Neola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Alessandro","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Raffaela","family":"Campanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cariati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Insabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9252","key":"10.1016\/j.prp.2021.153592_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.prp.2021.153592_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jsgi.2006.02.008","article-title":"Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor","volume":"13","author":"De Falco","year":"2006","journal-title":"J. Soc. Gynecol. Invest."},{"issue":"1","key":"10.1016\/j.prp.2021.153592_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2009.02.006","article-title":"Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes","volume":"144","author":"De Falco","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"10","key":"10.1016\/j.prp.2021.153592_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/nbm.1540","article-title":"Metabolic profile of intact tissue from uterine leiomyomas using high-resolution magic-angle-spinning 1H NMR spectroscopy","volume":"23","author":"Mazzei","year":"2010","journal-title":"NMR Biomed."},{"issue":"3","key":"10.1016\/j.prp.2021.153592_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2019.07.002","article-title":"Uterine smooth muscle tumors of unknown malignant potential: a challenging question","volume":"154","author":"Gadducci","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2021.153592_bib6","series-title":"World Health Organisation Classification of Tumors of Female Reproductive Organs","author":"Kurman","year":"2014"},{"issue":"8","key":"10.1016\/j.prp.2021.153592_bib7","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.clon.2017.05.005","article-title":"Borderline sarcomas and smooth muscle tumours of uncertain malignant potential","volume":"29","author":"Prewett","year":"2017","journal-title":"Clin. Oncol. (R. Coll. Radio.)"},{"issue":"5","key":"10.1016\/j.prp.2021.153592_bib8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/modpathol.2017.185","article-title":"Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors","volume":"31","author":"Croce","year":"2018","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2021.153592_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ajcp\/aqy178","article-title":"Immunohistochemical nuclear expression of \u03b2-catenin as a surrogate of CTNNB1 exon 3 mutation in endometrial cancer","volume":"151","author":"Travaglino","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2021.153592_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0b013e3181574d1e","article-title":"The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors","volume":"32","author":"Atkins","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2021.153592_bib11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/PAS.0b013e3181a02d1c","article-title":"Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases","volume":"33","author":"Ip","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2021.153592_bib12","first-page":"412","article-title":"Smooth muscle tumor of uncertain malignant potential (STUMP)--clinico-pathomorphological analysis of the cases and literature review","volume":"83","author":"Da\u0144ska-Bidzi\u0144ska","year":"2012","journal-title":"Ginekol. Pol."},{"issue":"2","key":"10.1016\/j.prp.2021.153592_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/cjp2.11","article-title":"Loss of ATRX and DAXX expression identifies poor prognosis for smooth muscle tumours of uncertain malignant potential and early stage uterine leiomyosarcoma","volume":"1","author":"Slatter","year":"2015","journal-title":"J. Pathol. Clin. Res"},{"issue":"4","key":"10.1016\/j.prp.2021.153592_bib14","first-page":"818","article-title":"Smooth muscle tumor of uncertain malignant potential (STUMP): a clinicopathologic analysis of 26 cases","volume":"13","author":"Zheng","year":"2020","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2021.153592_bib15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fonc.2020.00647","article-title":"Oncologic and reproductive outcomes of uterine smooth muscle tumor of uncertain malignant potential: a single center retrospective study of 67 cases","volume":"10","author":"Huo","year":"2020","journal-title":"Front Oncol."},{"issue":"8","key":"10.1016\/j.prp.2021.153592_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jogoh.2019.03.003","article-title":"Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): a single center experience","volume":"48","author":"Karata\u015fl\u0131","year":"2019","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"issue":"5","key":"10.1016\/j.prp.2021.153592_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051136","article-title":"The usefulness of immunohistochemistry in the differential diagnosis of lesions originating from the myometrium","volume":"20","author":"Rubisz","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.prp.2021.153592_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/apm.12988","article-title":"Nuclear expression of \u03b2-catenin in endometrial hyperplasia as marker of premalignancy","volume":"127","author":"Travaglino","year":"2019","journal-title":"APMIS"},{"key":"10.1016\/j.prp.2021.153592_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s12253-019-00684-3","article-title":"Diabetes mellitus is associated with occult cancer in endometrial hyperplasia","volume":"26","author":"Raffone","year":"2020","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.prp.2021.153592_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"issue":"8","key":"10.1016\/j.prp.2021.153592_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern Med"},{"issue":"1","key":"10.1016\/j.prp.2021.153592_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ajcp\/aqz132","article-title":"Congruence between 1994 WHO classification of endometrial hyperplasia and endometrial intraepithelial neoplasia system","volume":"153","author":"Travaglino","year":"2020","journal-title":"Am. J. Clin. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2021.153592_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/apm.12977","article-title":"Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer","volume":"127","author":"Raffone","year":"2019","journal-title":"APMIS"},{"issue":"6","key":"10.1016\/j.prp.2021.153592_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am. J. Surg. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2021.153592_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/modpathol.2009.122","article-title":"A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors","volume":"22","author":"Lee","year":"2009","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2021.153592_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA molecular groups of endometrial cancer: pooled data about prognosis","volume":"155","author":"Raffone","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2021.153592_bib27","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s12253-019-00784-0","article-title":"TCGA molecular subgroups in endometrial undifferentiated\/dedifferentiated carcinoma","volume":"26","author":"Travaglino","year":"2020","journal-title":"Pathol. Oncol. Res"},{"key":"10.1016\/j.prp.2021.153592_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ygyno.2020.01.008","article-title":"Histopathological characterization of ProMisE molecular groups of endometrial cancer","volume":"157","author":"Raffone","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2021.153592_bib29","first-page":"57","article-title":"Uncovering the role of p53 splice variants in human malignancy: a clinical perspective","volume":"7","author":"Surget","year":"2013","journal-title":"Onco Targets Ther."},{"issue":"Suppl 1","key":"10.1016\/j.prp.2021.153592_bib30","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J. Gynecol. Pathol."},{"issue":"7","key":"10.1016\/j.prp.2021.153592_bib31","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2559.2007.02699.x","article-title":"Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential","volume":"50","author":"O\u2019Neill","year":"2007","journal-title":"Histopathology"},{"issue":"6473","key":"10.1016\/j.prp.2021.153592_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","article-title":"Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers","volume":"368","author":"Nobori","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2021.153592_bib33","doi-asserted-by":"crossref","DOI":"10.4238\/gmr16019481","article-title":"Is differential expression of p16INK4a based on the classification of uterine smooth muscle tumors associated with a different prognosis? A meta-analysis","volume":"16","author":"Cao","year":"2017","journal-title":"Genet Mol. Res."},{"issue":"7","key":"10.1016\/j.prp.2021.153592_bib34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2559.2007.02699.x","article-title":"Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential","volume":"50","author":"O\u2019Neill","year":"2007","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.prp.2021.153592_bib35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00000478-199711000-00001","article-title":"Bizarre leiomyomas of the uterus: a comprehensive pathologic study of 24 cases with long-term follow-up","volume":"21","author":"Downes","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"issue":"11","key":"10.1016\/j.prp.2021.153592_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0046-8177(98)90248-9","article-title":"Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens","volume":"29","author":"Rudolph","year":"1998","journal-title":"Hum. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821002533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821002533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:47:05Z","timestamp":1759733225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821002533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"alternative-id":["S0344033821002533"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153592","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p53, p16 and ki67 as immunohistochemical prognostic markers in uterine smooth muscle tumors of uncertain malignant potential (STUMP)","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153592"}}